Results 121 to 130 of about 21,128 (300)

Management of primary angle closure glaucoma with cataract extraction

open access: yesZdravniški Vestnik, 2005
Background: We investigate the clinical result of phacoemulsification with foldable posterior chamber intraocular lens (PC-IOL) implantation in the management of primary angle closure glaucoma with cataract.Methods: We performed phacoemulsification with ...
Marija Ana Schwarzbartl-Pfeifer   +2 more
doaj  

Is angle closure glaucoma a problem in Nigeria?

open access: yes, 2014
Purpose: The aim of this study was to report the characteristics of angle closure glaucoma (ACG) in eye clinic patients of University College Hospital (UCH), Ibadan, Nigeria.Materials and Methods: A total of 336 consecutive new glaucoma patients of all ...
Sarimiye, TS, Olawoye, OO
core   +1 more source

Timing and duration of glucagon‐like peptide‐1 receptor agonist use and risk of nonarteritic anterior ischaemic optic neuropathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and nonarteritic anterior ischaemic optic neuropathy (NAION) in type 2 diabetes, examining treatment recency and cumulative duration. Methods This nationwide registry‐based nested case–control study utilizedz Danish health registries (1996 ...
Siar Niazi   +9 more
wiley   +1 more source

Demographics, clinical features and basic biometric parameters measured by low-coherence interferometry in fellow eyes of acute primary angle closure (Glaucoma) and chronic primary angle closure (Glaucoma).

open access: yes, 2018
Demographics, clinical features and basic biometric parameters measured by low-coherence interferometry in fellow eyes of acute primary angle closure (Glaucoma) and chronic primary angle closure (Glaucoma).
Yuhong Chen (120972)   +10 more
core   +1 more source

A prospective randomised comparison of two different stenting sutures when using the Baerveldt 101–350 aqueous shunt – Lab transition to clinical process

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The Baerveldt glaucoma drainage implant (BGI 101–350) is one of the most effective treatment options for managing refractory glaucoma. To mitigate early hypotony in non‐valved implants, intraluminal occluding sutures (IOSs) are commonly used.
Evripidis Sykakis   +7 more
wiley   +1 more source

Angle-closure Glaucoma: treatment [PDF]

open access: yesRevista da Associação Médica Brasileira, 2014
Prata, TS   +3 more
openaire   +4 more sources

Chlorhexidine 0.02% or polyhexamethylene biguanide 0.02% as the main treatment for Acanthamoeba keratitis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To report medical cure and treatment failure rates of Acanthamoeba keratitis (AK) with respect to type of treatment, disease stage and prognostic factors. Methods Electronic records were reviewed for 45 patients with PCR‐positive AK treated at the Department of Ophthalmology, Aarhus University Hospital, Denmark from 2012 to 2025 ...
Anders Ivarsen   +5 more
wiley   +1 more source

Angle-closure glaucoma: diagnosis [PDF]

open access: yesRevista da Associação Médica Brasileira, 2014
Jair, Giampani   +2 more
openaire   +2 more sources

Comparison of clinical and gonioscopic parameters in primary angle closure or primary angle closure glaucoma eyes requiring different number of anti-glaucoma medications after laser iridotomy.

open access: yes, 2016
Comparison of clinical and gonioscopic parameters in primary angle closure or primary angle closure glaucoma eyes requiring different number of anti-glaucoma medications after laser iridotomy.
Aparna Rao (530019)   +3 more
core   +1 more source

Duration‐Dependent Efficacy and Clinical Safety of Repeated Low‐Level Red‐Light Therapy for Paediatric Myopia: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Repeated low‐level red‐light (RLRL) therapy is a novel, non‐invasive intervention for controlling paediatric myopia progression. Despite increasing clinical use, questions remain regarding the magnitude, durability, and safety of treatment effects.
Lee‐Yuan Lin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy